The Food and Drug Administration sent a letter to the company on Tuesday accusing it of not doing enough to address the problem.
Ariel Zilber is a business reporter with a focus on national news in the United States. With bylines in publications such as the New York Post, The Courier-Mail, and Travel Trade Today Ltd., Ariel covers a wide range of topics including stock trading, retail sales, corporate earnings, and legal disputes. Their work has also been featured in The Daily Telegraph, News.com.au, MarketWatch, and other prominent media outlets.